Elimination of plasmids by new 4-quinolones.
作者信息
Weisser J, Wiedemann B
出版信息
Antimicrob Agents Chemother. 1985 Nov;28(5):700-2. doi: 10.1128/AAC.28.5.700.
Abstract
Nalidixic acid and six of the new 4-quinolones eliminated F'lac and various native R plasmids from Escherichia coli at one half or one quarter the MIC. Four of eight plasmids tested were cured by all derivatives, with frequencies from 10 to 98%. Quinolones did not eliminate all plasmids that were cured by novobiocin, and vice versa.
摘要
相似文献
1
Elimination of plasmids by new 4-quinolones.
Antimicrob Agents Chemother. 1985 Nov;28(5):700-2. doi: 10.1128/AAC.28.5.700.
2
Plasmid "curing" by some recently synthetized 4-quinolone compounds.
Chemioterapia. 1988 Oct;7(5):292-4.
3
Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.
J Antimicrob Chemother. 1986 Dec;18(6):667-74. doi: 10.1093/jac/18.6.667.
4
Novobiocin-induced elimination of F'lac and mini-F plasmids from Escherichia coli.
J Bacteriol. 1983 Dec;156(3):1165-70. doi: 10.1128/jb.156.3.1165-1170.1983.
5
Biological activity of new aza analogues of quinolones.
Folia Microbiol (Praha). 1997;42(3):193-8. doi: 10.1007/BF02818977.
6
Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.
Antimicrob Agents Chemother. 1984 May;25(5):586-90. doi: 10.1128/AAC.25.5.586.
7
[Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].
C R Seances Soc Biol Fil. 1985;179(5):696-9.
8
Elimination of plasmids pKM 101 and F'lac from Salmonella typhimurium and Escherichia coli by bisammonium salt. The effect of outer membrane pattern.
Folia Microbiol (Praha). 1991;36(3):240-5. doi: 10.1007/BF02814355.
9
Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones.
Antimicrob Agents Chemother. 1987 Apr;31(4):531-4. doi: 10.1128/AAC.31.4.531.
10
Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
Antimicrob Agents Chemother. 1987 Dec;31(12):1925-8. doi: 10.1128/AAC.31.12.1925.
引用本文的文献
1
Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes.
Crit Rev Microbiol. 2024 Nov;50(6):993-1010. doi: 10.1080/1040841X.2023.2233603. Epub 2023 Jul 18.
2
Carbapenem triggers dissemination of chromosomally integrated carbapenemase genes via conjugative plasmids in .
mSystems. 2023 Jun 29;8(3):e0127522. doi: 10.1128/msystems.01275-22. Epub 2023 Jun 5.
3
Evolution, persistence, and host adaption of a gonococcal AMR plasmid that emerged in the pre-antibiotic era.
PLoS Genet. 2023 May 15;19(5):e1010743. doi: 10.1371/journal.pgen.1010743. eCollection 2023 May.
4
Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.
Front Microbiol. 2020 May 6;11:761. doi: 10.3389/fmicb.2020.00761. eCollection 2020.
5
Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.
FEMS Microbiol Rev. 2018 Nov 1;42(6):781-804. doi: 10.1093/femsre/fuy031.
6
Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays.
Antimicrob Agents Chemother. 1993 Feb;37(2):213-7. doi: 10.1128/AAC.37.2.213.
7
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 1993 Jun;37(6):1289-96. doi: 10.1128/AAC.37.6.1289.
8
Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance.
Genitourin Med. 1995 Jun;71(3):141-4. doi: 10.1136/sti.71.3.141.
9
Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones.
Antimicrob Agents Chemother. 1987 Apr;31(4):531-4. doi: 10.1128/AAC.31.4.531.
10
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1987 Apr;33(4):346-91. doi: 10.2165/00003495-198733040-00003.
本文引用的文献
1
THE EFFECT OF ACRIDINE DYES ON MATING TYPE FACTORS IN ESCHERICHIA COLI.
Proc Natl Acad Sci U S A. 1960 Jan;46(1):57-64. doi: 10.1073/pnas.46.1.57.
2
Curing effect of clorobiocin on Escherichia coli plasmids.
Mol Gen Genet. 1982;186(1):153-5. doi: 10.1007/BF00422928.
3
The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.
J Antimicrob Chemother. 1981 Apr;7(4):379-88. doi: 10.1093/jac/7.4.379.
4
Curing of Escherichia coli K12 plasmids by coumermycin.
Mol Gen Genet. 1980 Apr;178(1):233-5. doi: 10.1007/BF00267235.
5
Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.
Antimicrob Agents Chemother. 1984 May;25(5):586-90. doi: 10.1128/AAC.25.5.586.
6
Novobiocin-induced elimination of F'lac and mini-F plasmids from Escherichia coli.
J Bacteriol. 1983 Dec;156(3):1165-70. doi: 10.1128/jb.156.3.1165-1170.1983.
7
Antagonism of the B subunit of DNA gyrase eliminates plasmids pBR322 and pMG110 from Escherichia coli.
J Bacteriol. 1982 Oct;152(1):338-44. doi: 10.1128/jb.152.1.338-344.1982.
8
Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA).
Antimicrob Agents Chemother. 1981 Mar;19(3):371-80. doi: 10.1128/AAC.19.3.371.
9
The problems of drug-resistant pathogenic bacteria. Practical effectiveness of agents curing R factors and plasmids.
Ann N Y Acad Sci. 1971 Jun 11;182:305-11. doi: 10.1111/j.1749-6632.1971.tb30666.x.
10
The problems of drug-resistant pathogenic bacteria. Elimination of bacterial episomes by DNA-complexing compounds.
Ann N Y Acad Sci. 1971 Jun 11;182:295-304. doi: 10.1111/j.1749-6632.1971.tb30665.x.
Zotero 插件